Skip to main content

Table 1 Nonpharmacological effects on glymphatic and meningeal lymphatic function in animal models of AD

From: Leveraging the glymphatic and meningeal lymphatic systems as therapeutic strategies in Alzheimer’s disease: an updated overview of nonpharmacological therapies

Ref

Intervention

Animal model

Glymphatic and meningeal lymphatic effects

Neurophysiological outcomes

Brain Structures

Behavioral outcomes

Ren et al. (2017) [24]

↑ PUFAs

(Fat-1 mice or fish oil supplementation)

Aβ (i.c.v.)

↑ CSF influx

↑ ISF solute clearance

↓ Aβ deposition

↓ Neuronal loss

Hippocampus

↑ Learning and memory

Zinchenko et al. (2019) [27]

tPBM

Aβ (i.c.v.)

↑ CSF drainage into dcLNs

↓ Aβ deposition

Hippocampus and cortex

Not investigated

Semyachkina-Glushkovskaya et al. (2021) [28]

tPBM

Aβ (i.c.v.)

↑ CSF drainage into dcLNs

↓ Aβ deposition

Not specified

↑ Learning and memory

Lee et al. (2020) [26]

FUS-MB

5xFAD mice

↑ CSF drainage into dcLNs

↓ Aβ deposition

↓ Gliosis

Entorhinal cortex and hippocampus

Not investigated

Lin et al. (2021) [114]

TMS

5xFAD mice

↑ CSF influx

↑ CSF drainage into dcLNs

↓ Aβ deposition

↓ Gliosis

↑ Neuronal activation

mPFC and hippocampus

↑ Learning and memory

Liang et al. (2021) [115]

Electroacupuncture

SAMP8 mice

↑ Polarized AQP4

↑ CSF influx

↓ Neuronal loss

↓ Aβ deposition

Hippocampus and cortex

↑ Learning and memory

Lyu et al. (2021) [116]

Yi-Zhi-Fang-Dai

Stroke (ischemia–reperfusion)

↑ Polarized AQP4

↓ Aβ deposition

Hippocampus and cortex

Not investigated

Zhang et al. (2021) [25]

NBP

APP/PS1 mice

↑ Polarized AQP4

↓ Aβ deposition

Hippocampus and cortex

↑ Learning and memory

Zheng et al. (2021) [117]

Xueshuantong

APP/PS1 mice

↑ Meningeal lymphatics morphology

 ↔ AQP4 Expression

↓ Aβ deposition

↓ Inflammation

Meninges

Not investigated

  1. ↑ increased/improved; ↓ reduced/decreased; ↔ unchanged. PUFAs n-3 polyunsaturated fatty acids, tPBM Transcranial photobiomodulation, FUS-MB Focused ultrasound therapy combined with intravenous injection of microtubules, TMS Transcranial magnetic stimulation, NBP L-3-n-butylphthalide